IHC analysis further revealed a gradient of VEGF-C expression across tumor stages, with higher levels in MSS T4N3 tumors compared to MSI counterparts and the disruption of VEGF-C -VEGFR-3 signaling among MSI T4N0. This evidence concerns the gene FLT4 and neoplasm.